VP Sales and Marketing, US Oncology/Breast Cancer

About the role

The VP Sales and Marketing, US Oncology/Breast Cancer is responsible for leading the US launch and commercialization strategy for a new breast cancer product planned for introduction in 2027. This executive will own the end-to-end commercial strategy, including brand strategy, sales leadership, launch readiness, forecasting, and cross-functional execution, to establish a strong foundation for a successful US oncology launch.

Responsibilities

• Lead all aspects of US launch readiness for 2027, including pre-launch planning, field force design, training, market development, and in-market execution.
• Analyze market trends, competitive intelligence, and customer insights to inform strategy and adapt tactics throughout the product lifecycle.
• Partner with Global colleagues to ensure alignment with brand vision and leverage best practices.
• Ensure compliance with US regulatory requirements, including FDA promotional standards, legal/compliance policies, and pharmacovigilance procedures.
• Lead, develop, and coach a high-performing US field organization, including 10 - 15 field-based representatives and 1 – 2 Regional Sales Directors.
• Develop and execute US field deployment plans, sales targets, and incentive programs to drive launch readiness and sustained performance.
• Monitor national sales performance metrics and optimize field execution strategies to achieve launch, growth, and profitability objectives in the US market.
• Foster a culture of accountability, collaboration, and continuous improvement focused on patient outcomes and commercial excellence.
• Lead development and execution of US brand strategy, positioning, and messaging for a new breast cancer product planned for launch in 2027.
• Design and deliver multi-channel marketing campaigns to drive awareness, trial, and loyalty among physicians and patients.
• Collaborate closely with Medical Affairs, Regulatory, and Market Access to ensure aligned and compliant execution.
• Manage agency partners and oversee creative, digital, and media planning.
• Develop and lead a strategic KOL engagement plan across the US breast cancer landscape, partnering with Medical Affairs to cultivate compliant relationships that inform brand strategy, support education initiatives, and strengthen launch readiness.
• Engage breast oncologists, oncology care teams, integrated delivery networks, and patient advocacy organizations to strengthen brand presence and trust.
• Partner with Market Access to shape reimbursement and payer strategies that support launch readiness, access, and long-term brand performance.
• Work with Medical Affairs to support KOL development and scientific exchange.
• Collaborate with Global counterparts to align on brand vision and best practices.
• Responsible for reporting Adverse Events and Technical Complaints to Tolmar Pharmacovigilance and Patient Safety (PSSP) that you learn of per SOP-00821, Pharmacovigilance and Technical Complaint Reporting.
• Own the brand P&L and manage the commercial budget to deliver on revenue, market share, profitability, and access objectives.
• Oversee performance tracking, forecasting, and business analytics to inform decisions.
• Ensure all activities comply with company policies, US healthcare regulations, and Pharmacovigilance & Patient Safety procedures.

Qualifications

• 15+ years of progressive biopharmaceutical experience, including significant US oncology commercial leadership experience and prior accountability for product launch and growth performance.
• Demonstrated success leading the US commercialization of specialty oncology brands, with breast cancer experience strongly preferred and the ability to translate market complexity into a clear, differentiated launch strategy.
• Strong executive leadership capability, including experience building, leading, and developing high-performing commercial organizations and second-line leaders in a matrixed environment.
• Advanced strategic and financial acumen, including ownership of brand P&L, forecasting, resource allocation, scenario planning, and trade-off decisions to optimize revenue, profitability, and long-term brand value.
• Deep understanding of the US oncology ecosystem, including community and academic oncology, integrated delivery networks, specialty pharmacy, payer dynamics, reimbursement pathways, and patient access barriers.
• Proven ability to influence and align senior leaders across Sales, Marketing, Market Access, Medical Affairs, Finance, Regulatory, Legal/Compliance, and Global functions to execute enterprise priorities.
• Strong external leadership presence with experience engaging key opinion leaders, advocacy organizations, strategic partners, and other senior stakeholders in a compliant and credible manner.
• Excellent analytical and business insight capabilities, including the ability to interpret market research, competitive intelligence, field insights, and performance data to make timely strategic decisions.
• Exceptional executive communication and influence skills, with the ability to synthesize complex issues, present recommendations clearly, and drive decisions with senior leadership and cross-functional teams.
• Entrepreneurial, agile, and patient-focused mindset with sound judgment, strong accountability, and the ability to lead through ambiguity in a fast-paced and highly regulated launch environment.